Govt Job for M.Pharm, M.Sc as Senior Research Fellow at ILS

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications from eligible Indian Nationals for the following position.

Post :Senior Research Fellow – Chromatin & Epigenetics: (01 no.)

Project Title : Auxiliary subunits of human SWI/SNF complex in normal myelopoiesis and leukemia.
Fellowship : Rs. 35,000/- per month+ @ 16% HRA

Eligibility Criteria : Candidates should have passed their M.Sc. / M.Tech. / M.Pharm. / M.V.Sc. or equivalent qualification in Life Sciences or allied subjects (Biochemistry/ Biotechnology/ Bioinformatics/ Microbiology etc.) with a minimum of 60% marks or equivalent grade point (50% for OBC/SC/ST) and at least two years of research experience.

Candidates should have qualified NET-JRF/ NET-LS/GATE/ICAR NET or any other national level examination. A copy of your CV (with two referees) must be provided along with the application.

Desirable : Candidates with expertise in programming, knowledge of ‘R’ (Bioconductor), statistics, Python, and C++, knowledge/hands-on experience in handling next-generation sequencing data and/or training in molecular biology would be preferred. Candidates are requested to provide a short write up on their programming skills.

Age Limit : The upper age limit of the candidate should be below 32 years as on the last date of application. Age relaxation will be given to the candidates as per Govt. of India rules.

Interested and eligible candidates may download the application form from the institute website (www.ils.res.in ) and apply along with the self-attested copies of mark sheets, certificates and experience details to “The Director, Institute of Life Sciences, Nalco Square, Bhubaneswar-751023”.

Super scribe the envelope with “Advt. no. / Date & Application for the position of Senior Research Fellow”. The decision of the Director regarding the selection of candidates will be final and no further correspondence will be entertained in this regard. Applications received after the last date will not be accepted.

Last date for receiving an application :14.04.2021
Date of display of shortlisted candidates in the ILS website : 16.04.2021
Date & time of interview : will be notified on the website
All communication will be through e-mail. No separate call letter will be issued to the candidates.

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks